Worth reading
50Recurring
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Revised forecast
Fiscal year ending March 2027 · Cumulative second quarter and full yearPrevious forecast published 12 May 2026Net Sales—→—million
—
Operating profit—→—million
—
Ordinary income—→—million
—
Profit attributable to owners of the parent—→—million
—
Net income per share—→—yen and sen
—
The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Reason for the revision
The consolidated earnings forecasts announced on 12 May 2026 were revised in light of recent business performance trends and other factors.
Details and amount of extraordinary loss
Loss on disposal of fixed assets: ¥85 million (three months ended 30 June 2026)
Previous-period resultsFirst quarter of the fiscal year ended March 2026: revenue ¥24,284 million, operating profit ¥3,939 million, ordinary profit ¥4,446 million, profit attributable to owners of the parent ¥3,047 million
Dividend forecast revisionThe forecast annual dividend for the fiscal year ending March 2027 was set at ¥30.00 (dividend at the end of the second quarter: ¥15.00; year-end dividend: ¥15.00), representing a revision from the most recently announced forecast. The difference from the previous forecast and the direction of the change were not disclosed.
Consolidated / non-consolidatedConsolidated
| Item | Details |
|---|---|
| Net Sales | Not disclosed → Second quarter (cumulative) 54,000 / Full year 108,000（Second quarter (cumulative) 10.6% (year on year) / Full year 8.0% (year on year)） |
| Operating profit | Not disclosed → Second quarter (cumulative) 10,300 / Full year 20,500（Second quarter (cumulative) 27.0% (year on year) / Full year 16.2% (year on year)） |
| Ordinary income | Not disclosed → Second quarter (cumulative) 11,200 / Full year 22,100（Second quarter (cumulative) 25.7% (year on year) / Full year 12.7% (year on year)） |
| Profit attributable to owners of the parent | Not disclosed → Second quarter (cumulative) 7,600 / Full year 14,800（Second quarter (cumulative) 12.5% (year on year) / Full year -4.3% (year on year)） |
| Net income per share | Not disclosed → Second quarter (cumulative) 62.40 / Full year 121.74 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Cumulative second quarter and full year |
| Publication date of previous forecast | 12 May 2026 |
| Previous-period results | First quarter of the fiscal year ended March 2026: revenue ¥24,284 million, operating profit ¥3,939 million, ordinary profit ¥4,446 million, profit attributable to owners of the parent ¥3,047 million |
| Reason for the revision | The consolidated earnings forecasts announced on 12 May 2026 were revised in light of recent business performance trends and other factors. |
| Details and amount of extraordinary loss | Loss on disposal of fixed assets: ¥85 million (three months ended 30 June 2026) |
| Dividend forecast revision | The forecast annual dividend for the fiscal year ending March 2027 was set at ¥30.00 (dividend at the end of the second quarter: ¥15.00; year-end dividend: ¥15.00), representing a revision from the most recently announced forecast. The difference from the previous forecast and the direction of the change were not disclosed. |
| Consolidated / non-consolidated | Consolidated |
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The revision was made in light of recent business performance trends and other factors. The company explained that first-quarter revenue and profit increased due to higher sales volumes, price revisions and expanded demand related to pharmaceuticals.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.